Androgen receptor activity in T cells limits checkpoint blockade efficacyXiangnan Guan, Amy E. Moran|Nature|2022Cited by 385
The ectonucleotidase CD39 identifies tumor-reactive CD8+ T cells predictive of immune checkpoint blockade efficacy in human lung cancerAndrew Chow, Charles M. Rudin, Yonit Lavin et al.|Immunity|2022Cited by 123
Anti-TIGIT antibody improves PD-L1 blockade through myeloid and Treg cellsXiangnan Guan, Namrata S. Patil, Ruozhen Hu et al.|Nature|2024Cited by 121